Cetin, B.; Benekli, M.; Turker, I.; Koral, L.; Ulas, A.; Dane, F.; Oksuzoglu, B.; Kaplan, M.A.; Koca, D.; Boruban, C.; Yilmaz, B.; Sevinc, A.; Berk, V.; Uncu, D.; Harputluoglu, H.; Coskun, U.; Buyukberber, S.
(2014)
Lapatinib is the first dual tyrosine kinase inhibitor of human epidermal growth factor receptor type 2 (HER2/neu) and epidermal growth factor receptor (EGFR). The present study evaluated the efficacy and tolerability of ...